ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 106 filers reported holding ATHIRA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,095 | -32.2% | 10,938 | -1.0% | 0.00% | – |
| Q2 2023 | $32,600 | -22.8% | 11,051 | -34.5% | 0.00% | – |
| Q1 2023 | $42,205 | -22.6% | 16,882 | -1.9% | 0.00% | – |
| Q4 2022 | $54,546 | -44.3% | 17,207 | -46.2% | 0.00% | -100.0% |
| Q2 2022 | $98,000 | -85.7% | 31,972 | +59.9% | 0.00% | -80.0% |
| Q4 2020 | $685,000 | -3.0% | 20,000 | -47.7% | 0.01% | -50.0% |
| Q3 2020 | $706,000 | – | 38,231 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |